Crossmark

IgA nephropathy after long-term treatment with infliximab for Crohn's disease Crohn's disease, a review of two cases

Crossref DOI link: https://doi.org/10.1016/j.nefroe.2023.02.010

Published Print: 2024-07

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Montero, Silvia Sánchez

Guix, Elena Monfa

Ausín, Monica Sierra

García, Francisco Izquierdo

Gómez, Benjamin León

Martinez-Rosero, Caterine Vanesa

Guerrero, Xhamy Yosue Martelli

Zaldumbide, Erika Jenelia Romero

Velasco, Mario Alfredo Prieto

Alvarez, Cristina Lucas

Lopez, Aranzazu Sastre

Kasabji, George Estifan
License Information

Text and Data Mining valid from 2024-07-01

Text and Data Mining valid from 2024-07-01

Version of Record valid from 2024-07-15
More Information

This article is maintained by: Elsevier

Article Title: IgA nephropathy after long-term treatment with infliximab for Crohn's disease Crohn's disease, a review of two cases

Journal Title: Nefrología (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.nefroe.2023.02.010

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.nefro.2023.02.007

Content Type: simple-article

Copyright: © 2023 Sociedad Española de Nefrología. Published by Elsevier España, S.L.U.